PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 128 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $174,000 | +54.0% | 18,979 | +62.8% | 0.02% | +30.8% |
| Q1 2021 | $113,000 | -21.0% | 11,657 | -17.5% | 0.01% | -43.5% |
| Q3 2020 | $143,000 | -49.8% | 14,124 | -58.1% | 0.02% | -58.9% |
| Q1 2020 | $285,000 | +9.2% | 33,731 | +13.0% | 0.06% | +33.3% |
| Q4 2019 | $261,000 | +4.4% | 29,844 | +28.5% | 0.04% | -4.5% |
| Q3 2019 | $250,000 | -27.7% | 23,217 | +160.3% | 0.04% | -22.8% |
| Q1 2019 | $346,000 | +10.2% | 8,921 | -42.2% | 0.06% | +5.6% |
| Q4 2018 | $314,000 | +33.6% | 15,430 | +340.9% | 0.05% | -14.3% |
| Q3 2016 | $235,000 | – | 3,500 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |